BRANFORD, Conn., Nov. 7, 2025 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has come to the Company’s attention that a report has been circulated…
